Biology subjects

Kent, L.

Publications and source records attributed to Kent, L..

5 recordsLinked to original sources

bioRxiv2026

BacPROTACs outperform inhibitors in Mycobacterium tuberculosis

Antibiotic discovery has long relied on occupancy-driven inhibition, leaving a vast number of potential bacterial targets undrugged.1 Targeted protein degradation offers a mechanistically distinct alternative to inhibition, yet its application to antibacterial drug discovery remains largely unexplored.2-4 Here we describe the development of first-in-class heterobifunctional bacterial proteolysis targeting chimeras (BacPROTACs) directed against an essential Mycobacterium tuberculosis protein, 4-phosphopantetheinyl transferase (PptT).5 Leveraging the modular architecture of BacPROTACs, we repurposed PptT inhibitors by incorporating them into degraders, yielding compounds with markedly improved antimycobacterial activity. Integrating in vitro and cellular approaches, we developed a characterisation pipeline to assess protein degradation in bacteria, applicable to future BacPROTAC programmes. Our study establishes targeted protein degradation as a strategy for antibacterial drug discovery.

microbiology↗

bioRxiv2026

Long-Term Human Skin Platform for Modeling Chronic Inflammation, Environmental Stress, and Therapeutic Intervention

Chronic inflammation drives tissue dysfunction and aging, yet the dynamic interplay between persistent inflammatory signaling and structural deterioration remains difficult to study in human-relevant systems. Here, an advanced long-term human skin platform is presented that preserves native tissue architecture and epidermal, stromal, and immune-associated molecular programs for up to 4 weeks. Using this system, sustained cytokine-driven inflammation was modeled, demonstrating chronic inflammatory transcriptional programs, progressive histopathological changes, and persistent inflammatory mediator secretion that were broadly suppressed by the JAK inhibitor tofacitinib. Using aged donor tissue, prolonged senolytic-associated treatment attenuated inflammatory and remodeling pathways. Finally, UVB exposure triggered coordinated stress and inflammatory responses that were partially mitigated using topical sunscreen, demonstrating compatibility with environmental stress modeling and topical intervention within preserved tissue architecture. Together, these findings establish a versatile human skin platform for modeling chronic inflammation, aging-associated tissue remodeling, and environmental stress, providing a translational framework for investigating skin tissue dysfunction and evaluating therapeutic interventions.

bioengineering↗

bioRxiv2026

Molecular determinants of cotranslational chaperone recruitment to nascent p53

Protein folding is fast relative to mRNA translation and nascent polypeptides begin to fold during their synthesis on the ribosome. The resulting cotranslational folding intermediates are accessible to diverse molecular chaperones that recognise incompletely folded client proteins. Here, we sought to understand how specific chaperone:client complexes are established during protein synthesis, using the chaperone-dependent tumor suppressor protein p53 as a model. By capturing interactomes at different points during p53 synthesis, we show that Hsp70, Hsp90 and TRiC bind competitively to nascent p53. While Hsp70 and Hsp90 bind promiscuously, TRiC discriminates between subtly different partially-folded states. TRiC recruitment is dictated by local cotranslational folding and exposure of specific sequence motifs, and this is tuned by cancer-associated mutations in the p53 DNA-binding domain. Nascent chain interactions with the ribosome surface disfavor TRiC binding, demonstrating that the ribosome imposes unique constraints on chaperone recruitment during protein synthesis. Our results establish molecular principles underlying chaperone prioritization during protein biogenesis.

biochemistry↗

bioRxiv2022

A missense mutation in zinc finger homeobox-3 (ZFHX3) impedes growth and alters metabolism and hypothalamic gene expression in mice.

A protein altering variant in the gene encoding zinc finger homeobox-3 (ZFHX3) has recently been associated with lower BMI in a human genome-wide association study. We investigated metabolic parameters in mice harbouring a missense mutation in Zfhx3 (Zfhx3Sci/+) and looked for altered in situ expression of transcripts that are associated with energy balance in the hypothalamus to understand how ZFHX3 may influence growth and metabolic effects. One year old male and female Zfhx3Sci/+ mice weighed less, had shorter body length, reduced fat mass, smaller mesenteric fat depots, and lower circulating insulin, leptin, and insulin-like growth factor-1 (IGF1) concentrations than Zfhx3+/+ littermates. In a second cohort of 9 - 20-week-old males and females, Zfhx3Sci/+ mice ate less than wildtype controls, in proportion to body weight. In a third cohort of female-only Zfhx3Sci/+ and Zfhx3+/+ mice that underwent metabolic phenotyping from 6 - 14 weeks old, Zfhx3Sci/+ mice weighed less and had lower lean mass and energy expenditure, but fat mass didnt differ. We detected increased expression of somatostatin, and decreased expression of growth hormone-releasing hormone and growth hormone-receptor mRNAs in the arcuate nucleus (ARC). Similarly, ARC expression of orexigenic neuropeptide Y was decreased and ventricular ependymal expression of orphan G protein-coupled receptor Gpr50 was decreased. We demonstrate for the first time an energy balance effect of the Zfhx3Sci mutation, likely by altering expression of key ARC neuropeptides to alter growth, food intake and energy expenditure.

physiology↗

bioRxiv2019

A putative enoyl-CoA hydratase contributes to biofilm formation and the antibiotic tolerance of Achromobacter xylosoxidans

Achromobacter xylosoxidans has attracted increasing attention as an emerging pathogen in patients with cystic fibrosis. Intrinsic resistance to several classes of antimicrobials and the ability to form robust biofilms in vivo contribute to the clinical manifestations of persistent A. xylosoxidans infection. Still, much of A. xylosoxidans biofilm formation remains uncharacterized due to the scarcity of existing genetic tools. Here we demonstrate a promising genetic system for use in A. xylosoxidans; generating a transposon mutant library which was then used to identify genes involved in biofilm development in vitro. We further described the effects of one of the genes found in the mutagenesis screen, encoding a putative enoyl-CoA hydratase, on biofilm structure and tolerance to antimicrobials. Through additional analysis, we find that a cis-2 fatty acid signaling compound is essential to A. xylosoxidans biofilm ultrastructure and maintenance. This work describes methods for the genetic manipulation of A. xylosoxidans and demonstrated their use to improve our understanding of A. xylosoxidans pathophysiology.

microbiology↗